Curbing Industry Sponsor\u27s Incentive to Design Post-Approval Trials That Are Suboptimal for Informing Prescribers but More Likely than Optimal Designs to Yield Favorable Results

Authors
Publication date
10 November 2011
Publisher
eRepository @ Seton Hall

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Seton Hall University eRepository

    redirect
    oaioai:scholarship.shu.edu:shlr-1...
    Last time updated on 18/04/2020